Adjunctive Dapagliflozin and Rituximab in Type B Insulin Resistance: A Case Report. // AACE Endocrinology and Diabetes. – URL: https://www.sciencedirect.com/science/article/pii/S3050915726002717?dgcid=rss_sd_all
Adjunctive Dapagliflozin and Rituximab in Type B Insulin Resistance: A Case Report. AACE Endocrinology and Diabetes. https://www.sciencedirect.com/science/article/pii/S3050915726002717?dgcid=rss_sd_all
“Adjunctive Dapagliflozin and Rituximab in Type B Insulin Resistance: A Case Report.” AACE Endocrinology and Diabetes.
@article{article32598,
title = {Adjunctive Dapagliflozin and Rituximab in Type B Insulin Resistance: A Case Report},
journal = {AACE Endocrinology and Diabetes},
url = {https://www.sciencedirect.com/science/article/pii/S3050915726002717?dgcid=rss_sd_all}
}